ESR1 and breast carcinoma: While some contrasting results have been reported, whereby hsa-miR-135a is either up or downregulated in differing cancers, hsa-miR-135a appears to function as a tumor suppressor in breast cancer and seems to be downregulated in human ER+ and triple negative (TN) breast cancers [65, 76, 77].